|
|
||||||||
Research Paper |
Biochemistry Department, Southern Research Institute, 2000 Ninth Avenue South, Birmingham, AL 35205, USA1
Author for correspondence: William B. Parker. Tel: +1 205 581 2797. Fax: +1 205 581 2877. e-mail: PARKER{at}SRI.ORG
2-Methyladenosine (methyl-ado) has demonstrated selective activity against Mycobacterium tuberculosis, which indicates that differences in the substrate preferences between mycobacterial and human purine metabolic enzymes can be exploited to develop novel drugs for the treatment of mycobacterial diseases. Therefore, in an effort to better understand the reasons for the anti-mycobacterial activity of methyl-ado, its metabolism has been characterized in Mycobacterium smegmatis. In a wild-type strain, methyl-ado was phosphorylated by adenosine kinase to methyl-AMP, which was further converted to methyl-ATP and incorporated into RNA. In contrast, a mutant strain of M. smegmatis was isolated that was resistant to methyl-ado, deficient in adenosine kinase activity and was not able to generate methyl-ado metabolites in cells treated with methyl-ado. These results indicated that phosphorylated metabolites of methyl-ado were responsible for the cytotoxic activity of this compound. Methyl-ado was not a substrate for either adenosine deaminase or purine-nucleoside phosphorylase from M. smegmatis. Treatment of M. smegmatis with methyl-ado resulted in the inhibition of ATP synthesis, which indicated that a metabolite of methyl-ado inhibited one of the enzymes involved in de novo purine synthesis. These studies demonstrated the importance of adenosine kinase in the activation of methyl-ado to toxic metabolites in M. smegmatis.
Keywords: purine metabolism, adenosine, adenosine kinase
Abbreviations: AD, adenosine deaminase; ado, adenosine; AK, adenosine kinase; APRT, adenine phosphoribosyltransferase; F-ade, 2-fluoroadenine; F-ado, 2-fluoroadenosine; ino, inosine; methyl-ade, 2-methyladenine; methyl-ado, 2-methyladenosine; PNP, purine-nucleoside phosphorylase; SAX-HPLC, strong anion exchange HPLC
This article has been cited by other articles:
![]() |
M. C. M. Reddy, S. K. Palaninathan, N. D. Shetty, J. L. Owen, M. D. Watson, and J. C. Sacchettini High Resolution Crystal Structures of Mycobacterium tuberculosis Adenosine Kinase: INSIGHTS INTO THE MECHANISM AND SPECIFICITY OF THIS NOVEL PROKARYOTIC ENZYME J. Biol. Chem., September 14, 2007; 282(37): 27334 - 27342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Long, V. Escuyer, and W. B. Parker Identification and Characterization of a Unique Adenosine Kinase from Mycobacterium tuberculosis J. Bacteriol., November 15, 2003; 185(22): 6548 - 6555. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Barrow, L. Westbrook, N. Bansal, W. J. Suling, J. A. Maddry, W. B. Parker, and W. W. Barrow Antimycobacterial activity of 2-methyl-adenosine J. Antimicrob. Chemother., November 1, 2003; 52(5): 801 - 808. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |